Eugene

[email protected]

LATEST

BI, OSE in $1.3-Billion-Plus Immuno-Oncology Deal
By

By
Boehringer Ingelheim (BI) and OSE Immunotherapeutics, a Nantes, France-headquartered biopharmaceutical company developing immunotherapies, have signed a worldwide collaboration and license agreement to jointly develop OSE-172, a signal regulatory protein (SIRP)-alpha…

Novartis To Acquire Gene-Therapy Company AveXis for $8.7 Billion
By

By
Novartis has signed an agreement and plan of merger to acquire AveXis, a Bannockburn, Illinois-headquartered clinical-stage gene-therapy company, for $218 per share or a total of $8.7 billion in cash.…

Eli Lilly Signs $473-Million Deal for Encapsulated Cell Therapies for Treating Diabetes
By

By
Eli Lilly and Company and Sigilon Therapeutics, a Cambridge, Massachusetts-based cell-therapy company, have formed a global collaboration worth up to $473 million to develop encapsulated cell therapies for the potential…

Fujifilm Agrees To Buy Two Cell-Culture Media Companies for $800 Million
By

By
Fujifilm has agreed to acquire two cell-culture media companies, Santa Ana, California-based Irvine Scientific Sales Company (ISUS) and Tokyo, Japan-based IS Japan (ISJ), for approximately $800 million. The company also…

Corning To Build Pharma Glass Packaging Mfg Facility in North Carolina
By

By
Corning, a material-sciences company, has announced plans to build a high-volume pharmaceutical glass packaging manufacturing facility in Durham County, North Carolina to support production of Corning Valor Glass, a new…

Celgene President and COO Departs; Leadership Team Structure Modified
By

By
Celgene announced on April 2, 2018 that Scott A. Smith, President and Chief Operating Officer (COO), is leaving the company effective immediately. His primary responsibilities will be assumed by Chairman…

AbbVie, Samsung Bioepis Reach Settlement on Biosimilar of AbbVie’s Humira
By

By
AbbVie has announced the global resolution of all intellectual property-related litigation with Samsung Bioepis, a joint venture between Samsung BioLogics, an Incheon, South Korea-based contract biologics manufacturer, and Biogen, over…

Pfizer, Allogene Sign Pact for Cell Therapies
By

By
Pfizer and Allogene Therapeutics, a San Francisco, California-headquartered biopharmaceutical company, have signed an asset contribution agreement for Pfizer’s portfolio of assets related to allogeneic chimeric antigen receptor T cell (CAR-T)…

Eisai, Nichi-Iko Partner in Generics
By

By
Eisai and Nichi-Iko Pharmaceutical, a Japan-headquartered generic-drug company, have entered into a capital and business alliance as well as a share transfer agreement relating to their generic pharmaceuticals businesses, which…

Takeda Considers Proposal to Acquire Shire
By

By
Takeda Pharmaceutical Company Ltd. is considering making an approach to Shire, a Dublin, Ireland, headquartered pharmaceutical company, regarding a possible offer for the company. In a statement, Takeda said such…